D-hormone derivatives for the treatment of osteoporosis: From alfacalcidol to eldecalcitol

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 12, 2009, Pages 1416-1422

  Kubodera, Noboru ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

22 OXACALCITRIOL; ALENDRONIC ACID; ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; COLECALCIFEROL; D HORMONE DERIVATIVE; ELDECALCITOL; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SODIUM IBANDRONATE; SODIUM RISEDRONATE; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

BONE DENSITY; BONE STRENGTH; CALCIUM ABSORPTION; CELL DIFFERENTIATION; CLINICAL TRIAL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; FRACTURE; HUMAN; HYDROXYLATION; HYPOCALCEMIA; ISOMERIZATION; KIDNEY INJURY; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PSORIASIS VULGARIS; RHEUMATOID ARTHRITIS; RICKETS; SECONDARY HYPERPARATHYROIDISM; SHORT SURVEY; VITAMIN D DEFICIENCY;

CALCITRIOL; CALCIUM; CHOLECALCIFEROL; ERGOCALCIFEROLS; HUMANS; HYDROXYCHOLECALCIFEROLS; OSTEOPOROSIS; VITAMIN D;

EID: 74049140398     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709789957486     Document Type: Short Survey

References (22)

1. DeLuca, H.F. In Historical overview in Vitamin D; Feldman, D.; Francis H.; Glorieux, J.; Pike, W. Eds.; Academic Press: San Diego, 1997; pp. 3-11.
2. nd ed.; Feldman, D.; Francis H.; Glorieux, J.; Pike, W. Eds.; Elsevier Academic Press: Burlington, 2005; pp. 3-12.
3. nd ed.; Feldman, D.; Francis H.; Glorieux, J.; Pike, W. Eds.; Elsevier Academic Press: Burlington, 2005; pp. 117-34.
4. nd ed.; Feldman, D.; Francis H.; Glorieux, J.; Pike, W. Eds.; Elsevier Academic Press: Burlington, 2005; pp. 15-36.
5. nd ed.; Feldman, D.; Francis H.; Glorieux, J.; Pike, W. Eds.; Elsevier Academic Press: Burlington, 2005; pp. 167-91.
6. Higuchi, Y.; Sato, K.; Nanjo, M.; Isogai, T.; Takeda, S.; Kumaki, K.; Nishii, Y. 1α-Hydroxycholecalciferol prevents osteoporosis induced by ovariectomy in the rats. Vitamins, 1994, 68, 87-93.
7. Nishii, Y. Active vitamin D and its analogs as drugs for the treatment of osteoporosis: advantages and problems. J. Bone Miner. Metab., 2002, 20, 57-65.
8. Shiraishi, A.; Higashi, S.; Ohakawa, H.; Kubodera, N.; Hirasawa, T.; Ezawa, I.; Ikeda, K.; Ogata, E. The advantage of alfacalcidol over vitamin D in the treatment of osteoporosis. Calcif. Tissue Int., 1999, 65, 311-6.
9. Papapoulos, S.E. In Bisphosphonates pharmacology and use in the treatment of osteoporosis in Osteoporosis; Marcus, R.; Feldman, D.; Kelsey, J. Eds.; Academic Press: San Diego, 1996; pp. 1209-34.
10. Nishii, Y.; Okano, T. History of the development of new vitamin D analogs: studies on 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy) calcitriol (ED-71). Steroids, 2001, 66, 137-46.
11. 3 analogues. J. Syn. Org. Chem. Jpn, 2005, 63, 728-38 and internal information at Chugai Pharmaceutical Co., Ltd.
12. 3. Proc. Natl. Acad. Sci. USA, 1981, 78, 4990-4.
13. Bouillon, R.; Okamura, W.H.; Norman, A.W. Structure-function relationships in the vitamin D endocrine system. Endocr. Rev., 1995, 16, 200-57.
14. nd ed.; Feldman, D.; Francis H.; Glorieux, J.; Pike, W. Eds.; Elsevier Academic Press: Burlington, 2005; pp. 1405-22.
15. nd ed.; Feldman, D.; Francis H.; Glorieux, J.; Pike, W. Eds.; Elsevier Academic Press: Burlington, 2005; pp. 1525-41.
16. Uchiyama, Y.; Higuchi, Y.; Takeda, S.; Masaki, T.; Shira-Ishi, A.; Sato, K.; Kubodera, N.; Ikeda, K.; Ogata. E. ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Bone, 2002, 30, 582-8.
17. Kubodera, N.; Tsuji, N.; Uchiyama, Y.; Endo, K. A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients. J. Cell Biochem., 2003, 88, 286-9.
18. Ikeda, K.; Ogata, E. The effect of vitamin D on osteoblasts and osteoclasts. Curr. Opin. Orthop., 1999, 10, 339-43.
19. 3 derivative, on calcium metabolism. Biochem. Biophys. Res. Commun., 1989, 163, 1444-9.
20. Matsumoto, T.; Miki, T.; Hagino, H.; Sugimoto, T.; Okamoto, S.; Hirota, T.; Tanigawara, Y.; Hayashi, Y.; Fukunaga, M.; Shiraki, M.; Nakamura, T. A new vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial. J. Clin. Endocrinol. Metab., 2005, 90, 5031-6.
21. Need A.G.; Nordin B.E.C. Misconceptions - vitamin D insufficiency causes malabsorption of calcium. Bone, 2008, 42, 1021-4.
22. 3 analogs. Curr. Bioact. Compd., 2006, 2, 301-15.